The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Kline, Justin P.
PropertyValue
keywords Non-hodgkkin lymphoma
keywords Hodgkin Lymphoma
overview Dr. Kline is a medical oncologist who specializes in the treatment of patients with Hodgkin and non-Hodgkin lymphoma, including stem cell transplantation and CAR T cell therapy. He has expertise in the development and use of immunotherapy, and his lab research is focused on overcoming immune evasion pathways activated in blood cancers and on improving the effectiveness of immune-based treatments for people with lymphoma.
One or more keywords matched the following items that are connected to Kline, Justin P.
Item TypeName
Concept Lymphoma, Follicular
Concept Lymphoma
Concept Lymphoma, B-Cell
Concept Lymphoma, Large B-Cell, Diffuse
Concept Precursor Cell Lymphoblastic Leukemia-Lymphoma
Concept Lymphoma, Non-Hodgkin
Concept Lymphoma, T-Cell, Peripheral
Academic Article Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
Academic Article Will changing the face of WT1 make it more attractive to T cells?
Academic Article Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
Academic Article Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
Academic Article Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.
Academic Article T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse.
Academic Article A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas.
Academic Article A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-Hodgkin lymphoma.
Academic Article Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
Academic Article A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.
Academic Article Update on checkpoint blockade therapy for lymphoma.
Academic Article Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment.
Academic Article The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
Academic Article Highly clonal regulatory T-cell population in follicular lymphoma - inverse correlation with the diversity of CD8+ T cells.
Academic Article PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation.
Academic Article Emerging role of checkpoint blockade therapy in lymphoma.
Academic Article Mechanisms of Immune Tolerance in Leukemia and Lymphoma.
Academic Article Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
Academic Article Characterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantation.
Academic Article Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
Grant PD-L1 gene amplifications and the "T cell-inflamed" phenotype in diffuse large B cell lymphoma
Academic Article Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma.
Academic Article The immune landscape and response to immune checkpoint blockade therapy in lymphoma.
Academic Article Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
Academic Article A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Search Criteria
  • Lymphoma